Six human trials. 900 participants. Positive Phase IIa. Then the pivotal Phase IIb failed at every dose. Development terminated 2007.
This post is available to premium subscribers. Subscribe to access the full article and all premium content.
For research and educational purposes only · Not medical advice · Consult a qualified physician before any human use